Tag: Cancer medication

Approximately 80% of cancer treatments involve a combination of therapies. Versavo 400, a biosimilar of bevacizumab, is a targeted anti-cancer drug used in combination with other chemotherapy drugs for treating several types of advanced cancers.

In 2021, manufacturer list prices for dose levels of Gleostine (lomustine) ranged from $90 to over $1,000 per capsule, leading to average patient costs of $1,500 to $3,000 every six weeks. The question of how much does Gleostine cost reveals a complex landscape of single-source manufacturing, lack of generic availability, and limited insurance coverage. This guide explains the reasons for the high cost and outlines potential avenues for financial relief.

Globally, millions of illicit Captagon tablets are seized annually, highlighting a serious issue with counterfeit stimulants. However, the term "captain pills" can also refer to a completely different, legitimate medication: the cancer treatment Captain (Capecitabine). Understanding the context is critical for distinguishing between these two very different substances.

Rozlytrek (entrectinib) received its initial accelerated approval from the U.S. Food and Drug Administration (FDA) in August 2019 for specific types of cancer. The answer to who makes Rozlytrek involves a complex history of development and acquisition, leading to the current manufacturer, Genentech, a member of the Roche Group.